MARKET

FWP

FWP

Forward Pharma A/S
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.01
-0.09
-1.76%
Closed 16:00 05/27 EDT
OPEN
5.01
PREV CLOSE
5.10
HIGH
5.19
LOW
5.00
VOLUME
2.32K
TURNOVER
8.48K
52 WEEK HIGH
20.31
52 WEEK LOW
4.850
MARKET CAP
35.53M
P/E (TTM)
-18.4462
1D
5D
1M
3M
1Y
5Y
European ADRs Move Higher in Wednesday Trading
MT Newswires · 04/13 11:05
Forward Pharma GAAP EPS of -$0.02
Forward Pharma press release (NASDAQ:FWP): FY GAAP EPS of -$0.02. At December 31, 2021, the Group had cash and cash equivalents of $70.8M and working capital of $70.8M. "We believe
Seekingalpha · 04/11 04:23
Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021
COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results for the year ended December 31, 2021....
GlobeNewswire · 04/08 21:25
Forward Pharma granted Australian patent linked to multiple sclerosis therapy
The Australian government has awarded Forward Pharma (FWP +4.2%) a key patent linked to multiple sclerosis (MS) therapy. According to the details published by IP Australia Thursday, the patent bearing the application
Seekingalpha · 12/23/2021 16:49
Forward Pharma Australian Gov't. Patent Listing For Co.'s 'Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose'; Low-Volume Stock Halted On Circuit Breaker Following Circulation Of Patent, Halted Up 14%
http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2019268049#
Benzinga · 12/23/2021 15:44
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Benzinga · 12/16/2021 23:03
Forward Pharma Has Been Granted Australian Patent Titled 'Combination therapy for treatment of multiple sclerosis'
http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2020201290#
Benzinga · 12/16/2021 18:22
BRIEF-Forward Pharma A/S Files For Resale Of Up To 70.4 Million Ordinary Shares
reuters.com · 12/13/2021 22:20
More
No Data
Learn about the latest financial forecast of FWP. Analyze the recent business situations of Forward Pharma A/S through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average FWP stock price target is 37.00 with a high estimate of 37.00 and a low estimate of 37.00.
High37.00
Average37.00
Low37.00
Current 5.01
EPS
Actual
Estimate
-0.22-0.17-0.11-0.06
Q1 2016
Q2 2016
Q3 2016
Q4 2016
Q1 2017
Institutional Holdings
Institutions: 19
Institutional Holdings: 789.48K
% Owned: 11.13%
Shares Outstanding: 7.09M
TypeInstitutionsShares
Increased
0
0
New
2
62.33K
Decreased
5
26.52K
Sold Out
1
1.24K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+3.72%
Pharmaceuticals & Medical Research
+1.28%
Key Executives
Chief Executive Officer/IR Contact Officer
Claus Svendsen
Controller/Vice President
Thomas Carbone
Director/Chairman
Florian Schonharting
Director
Torsten Goesch
Director
Jakob Larsen
Independent Director
Grant Lawrence
Independent Director
Duncan Moore
No Data
No Data
About FWP
Forward Pharma A/S is a Denmark-based bio-pharmaceutical company. It is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The Company is headquartered in Copenhagen, Denmark.

Webull offers kinds of Forward Pharma A/S stock information, including NASDAQ:FWP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FWP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FWP stock methods without spending real money on the virtual paper trading platform.